Area of research
Epidemiology · Pharmacology
Research interest
Research focused on Thyroid and Sulindac, with related work in Somatostatin receptor 2, Somatostatin receptor, Thyroid cancer. Notable publications include 'The Role of Notch3 in Cancer', 'A Novel Sulindac Derivative that Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and β-Catenin Transcriptional Activity', and 'Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy'.
Characterizing SSTR2 expression and modulation for targeted imaging and therapy in preclinical models of triple-negative breast cancer
PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [<sup>89</sup>Zr]Zr-TR1402
Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer
Voltage-Gated Sodium Channel NaV1.7 Inhibitors with Potent Anticancer Activities in Medullary Thyroid Cancer Cells
Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats
Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment
Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy
Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatment
Pulmonary Carcinoid Surface Receptor Modulation Using Histone Deacetylase Inhibitors
The Role of <i>Notch3</i> in Cancer
A Novel Sulindac Derivative that Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and β-Catenin Transcriptional Activity